Symprove was founded in 2002 and commitment to research has always been at the core of the company’s values.
We believe in supporting researchers, healthcare professionals and businesses to increase their knowledge of gut health and the microbiome.
Several scientific studies have been carried out on Symprove. Studies published so far have looked at:
Effective delivery system – survival of the Symprove bacteria through the Gastrointestinal tract.
Gut health and how this is impacted by use of multistrain live bacteria products
Emerging research – the impact of live bacteria products on other components of the microflora and implications for the maintenance of human health.